UK Markets open in 5 hrs 58 mins

Editas Medicine, Inc. (0IFK.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
32.12+0.52 (+1.65%)
At close: 5:38PM BST
Currency in USD

Valuation measures

Market cap (intra-day) 51.57B
Enterprise value 31.85B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)17.34
Price/book (mrq)5.11
Enterprise value/revenue 320.35
Enterprise value/EBITDA 7-14.11

Trading information

Stock price history

Beta (5Y monthly) 2.01
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 332.12
52-week low 332.12
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 547.5M
Implied shares outstanding 6N/A
Float 66.35M
% held by insiders 10.20%
% held by institutions 171.94%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin -127.82%
Operating margin (ttm)-148.61%

Management effectiveness

Return on assets (ttm)-15.58%
Return on equity (ttm)-35.36%

Income statement

Revenue (ttm)90.73M
Revenue per share (ttm)1.55
Quarterly revenue growth (yoy)-7.00%
Gross profit (ttm)-67.26M
EBITDA -130.88M
Net income avi to common (ttm)-115.98M
Diluted EPS (ttm)-1.98
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)402.11M
Total cash per share (mrq)5.98
Total debt (mrq)26.14M
Total debt/equity (mrq)6.64
Current ratio (mrq)7.20
Book value per share (mrq)6.29

Cash flow statement

Operating cash flow (ttm)-179.84M
Levered free cash flow (ttm)-77.36M